Understanding of COVID-19 Based on Current Evidence

J Med Virol. 2020 Jun;92(6):548-551. doi: 10.1002/jmv.25722. Epub 2020 Mar 5.

Abstract

Since December 2019, a series of unexplained pneumonia cases have been reported in Wuhan, China. On 12 January 2020, the World Health Organization (WHO) temporarily named this new virus as the 2019 novel coronavirus (2019-nCoV). On 11 February 2020, the WHO officially named the disease caused by the 2019-nCoV as coronavirus disease (COVID-19). The COVID-19 epidemic is spreading all over the world, especially in China. Based on the published evidence, we systematically discuss the characteristics of COVID-19 in the hope of providing a reference for future studies and help for the prevention and control of the COVID-19 epidemic.

Keywords: 2019-nCoV; COVID-19; SARS-CoV-2; coronavirus; epidemiology; pneumonia.

Publication types

  • Review

MeSH terms

  • Adenosine Monophosphate / analogs & derivatives
  • Adenosine Monophosphate / therapeutic use
  • Adrenal Cortex Hormones / therapeutic use
  • Alanine / analogs & derivatives
  • Alanine / therapeutic use
  • Animals
  • Antiviral Agents / therapeutic use*
  • Betacoronavirus / drug effects
  • Betacoronavirus / genetics
  • Betacoronavirus / pathogenicity*
  • China / epidemiology
  • Chiroptera / virology
  • Communicable Disease Control / organization & administration*
  • Coronavirus Infections / diagnosis
  • Coronavirus Infections / drug therapy
  • Coronavirus Infections / mortality
  • Coronavirus Infections / transmission*
  • Disease Management
  • Humans
  • Oseltamivir / therapeutic use
  • Pandemics*
  • Pneumonia, Viral / diagnosis
  • Pneumonia, Viral / drug therapy
  • Pneumonia, Viral / mortality
  • Pneumonia, Viral / transmission*
  • Survival Analysis

Substances

  • Adrenal Cortex Hormones
  • Antiviral Agents
  • Oseltamivir
  • remdesivir
  • Adenosine Monophosphate
  • Alanine

Supplementary concepts

  • COVID-19
  • severe acute respiratory syndrome coronavirus 2